Corticosteroid for Diabetic Macular Edema (DME) Study
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
Our current goals include confirming inflammation mediators are biomarkers of DR and DME The Aim of this project is to measure aqueous PGE2 and inflammatory cytokines before and after treatment of DME with intravitreal corticosteroid injections. We want to continue the study for one more year as our initial data analysis from the original INSPIRE study shows a possible direct correlation between aqueous biomarkers and DME. We propose treating the DME with corticosteroid to assess the effect upon the intraocular cytokines with inflammation is suppressed.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
• Adult patients age 18 years or older with type II diabetes, with baseline moderate NPDR and DME.
Locations
United States
Tennessee
Vanderbilt Eye Institute
RECRUITING
Nashville
Contact Information
Primary
Stephen J Kim, MD
lindsay.veach@vumc.org
615-936-2020
Time Frame
Start Date: 2026-04-07
Estimated Completion Date: 2029-03
Participants
Target number of participants: 20
Treatments
Active_comparator: intravitreal corticosteroid implant
Related Therapeutic Areas
Sponsors
Leads: Vanderbilt University Medical Center